{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:19:49Z","timestamp":1790104789210,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s15010-017-1059-3","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T15:48:05Z","timestamp":1502898485000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience"],"prefix":"10.1007","volume":"46","author":[{"given":"Hiram","family":"Villanueva-Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio de J.","family":"Trevi\u00f1o-Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria M.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Camacho-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Castillo-Reyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra G.","family":"Galindo-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel F.","family":"Mart\u00ednez-Res\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin N Am. 2016;30:179\u2013206.","journal-title":"Infect Dis Clin N Am"},{"key":"1059_CR2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS. 2009;23:525\u201330.","journal-title":"AIDS"},{"key":"1059_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cid\/cir756","volume":"54","author":"KA Marr","year":"2012","unstructured":"Marr KA, Datta K, Pirofski LA, Barnes R. Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency? Clin Infect Dis. 2012;54:153\u20134.","journal-title":"Clin Infect Dis"},{"key":"1059_CR4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58:736\u201345.","journal-title":"Clin Infect Dis"},{"key":"1059_CR5","doi-asserted-by":"publisher","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17:873\u201381. doi: 10.1016\/S1473-3099(17)30243-8 .","DOI":"10.1016\/S1473-3099(17)30243-8"},{"key":"1059_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12981-016-0126-7","volume":"13","author":"S Srichatrapimuk","year":"2016","unstructured":"Srichatrapimuk S, Sungkanuparph S. Integrated therapy for HIV and cryptococcosis. AIDS Res Ther. 2016;13:42.","journal-title":"AIDS Res Ther."},{"key":"1059_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291\u2013322.","journal-title":"Clin Infect Dis"},{"key":"1059_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","volume":"337","author":"CM Horst van der","year":"1997","unstructured":"van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15\u201321.","journal-title":"N Engl J Med"},{"key":"1059_CR9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","volume":"317","author":"WE Dismukes","year":"1987","unstructured":"Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987;317:334\u201341.","journal-title":"N Engl J Med"},{"key":"1059_CR10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/cmi.12590","volume":"18","author":"C Coelho","year":"2016","unstructured":"Coelho C, Casadevall A. Cryptococcal therapies and drug targets: the old, the new and the promising. Cell Microbiol. 2016;18:792\u20139.","journal-title":"Cell Microbiol"},{"key":"1059_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/315649","volume":"182","author":"TS Harrison","year":"2000","unstructured":"Harrison TS, Griffin GE, Levitz SM. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans. J Infect Dis. 2000;182:283\u20139.","journal-title":"J Infect Dis"},{"key":"1059_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrmicro1680","volume":"5","author":"WJ Steinbach","year":"2007","unstructured":"Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol. 2007;5:418\u201330.","journal-title":"Nat Rev Microbiol"},{"key":"1059_CR13","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","volume":"56","author":"B Zhai","year":"2012","unstructured":"Zhai B, Wu C, Wang L, Sachs MS, Lin X. The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob Agents Chemother. 2012;56:3758\u201366.","journal-title":"Antimicrob Agents Chemother"},{"key":"1059_CR14","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","volume":"59","author":"KD Smith","year":"2015","unstructured":"Smith KD, Achan B, Hullsiek KH, McDonald TR, Okagaki LH, Alhadab AA, et al. Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda. Antimicrob Agents Chemother. 2015;59:7197\u2013204.","journal-title":"Antimicrob Agents Chemother"},{"key":"1059_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mmy\/myv109","volume":"54","author":"J Trevi\u00f1o-Rangel Rde","year":"2016","unstructured":"Trevi\u00f1o-Rangel Rde J, Villanueva-Lozano H, Hern\u00e1ndez-Rodr\u00edguez P, Mart\u00ednez-Res\u00e9ndez MF, Garc\u00eda-Ju\u00e1rez J, Rodr\u00edguez-Rocha H, et al. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays. Med Mycol. 2016;54:280\u20136.","journal-title":"Med Mycol"},{"key":"1059_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","volume":"45","author":"T Bicanic","year":"2007","unstructured":"Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007;45:76\u201380.","journal-title":"Clin Infect Dis"},{"key":"1059_CR17","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Wayne: CLSI; 2008 (Approved standard M27-A3).","edition":"3"},{"key":"1059_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","volume":"30","author":"JR Graybill","year":"2000","unstructured":"Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30:47\u201354.","journal-title":"Clin Infect Dis"},{"key":"1059_CR19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","volume":"23","author":"T Bicanic","year":"2009","unstructured":"Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009;23:701\u20136.","journal-title":"AIDS."},{"key":"1059_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","volume":"58","author":"T Kabanda","year":"2014","unstructured":"Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis. 2014;58:113\u20136.","journal-title":"Clin Infect Dis"},{"key":"1059_CR21","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","volume":"7","author":"DR Boulware","year":"2010","unstructured":"Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7:e1000384.","journal-title":"PLoS Med."},{"key":"1059_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","volume":"192","author":"AE Brouwer","year":"2005","unstructured":"Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, et al. Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis. 2005;192:681\u20134.","journal-title":"J Infect Dis"},{"key":"1059_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","volume":"78","author":"JR Perfect","year":"2015","unstructured":"Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. Fungal Genet Biol. 2015;78:49\u201354.","journal-title":"Fungal Genet Biol"},{"key":"1059_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-015-1023-8","volume":"15","author":"YC Chen","year":"2015","unstructured":"Chen YC, Chang TY, Liu JW, Chen FJ, Chien CC, Lee CH, et al. Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis. 2015;15:277.","journal-title":"BMC Infect Dis"},{"key":"1059_CR25","doi-asserted-by":"crossref","first-page":"e1002870","DOI":"10.1371\/journal.ppat.1002870","volume":"8","author":"A Butts","year":"2012","unstructured":"Butts A, Krysan DJ. Antifungal drug discovery: something old and something new. PLoS Pathog. 2012;8:e1002870.","journal-title":"PLoS Pathog"},{"key":"1059_CR26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","volume":"16","author":"J Rhein","year":"2016","unstructured":"Rhein J, Morawski BM, Hullsiek KH, Nabeta HW, Kiggundu R, Tugume L, et al. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis. 2016;16:809\u201318.","journal-title":"Lancet Infect Dis."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-017-1059-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T07:38:59Z","timestamp":1659339539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-017-1059-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s15010-017-1059-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]}}}